These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 348529)

  • 41. [Current data on the etiopathogenesis of multiple sclerosis].
    Verdeş F
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1977; 22(3):189-99. PubMed ID: 337441
    [No Abstract]   [Full Text] [Related]  

  • 42. Value of central nervous system IgG daily synthesis determination in the diagnosis of multiple sclerosis.
    Mandler R; Goren H; Valenzuela R
    Neurology; 1982 Mar; 32(3):296-8. PubMed ID: 7199643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CNS IgG synthesis in multiple sclerosis: choosing the right reference population.
    Shugar G
    Am J Clin Pathol; 1983 Jan; 79(1):144-5. PubMed ID: 6849294
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibody responses to measles virus and canine distemper virus in multiple sclerosis.
    Krakowka S; Miele JA; Mathes LE; Metzler AE
    Ann Neurol; 1983 Nov; 14(5):533-8. PubMed ID: 6197006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Multiple sclerosis--an immunological disease].
    Vedeler CA
    Tidsskr Nor Laegeforen; 1991 Mar; 111(8):944-7. PubMed ID: 2042210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NMO-IgG in the diagnosis of neuromyelitis optica.
    Jarius S; Franciotta D; Bergamaschi R; Wright H; Littleton E; Palace J; Hohlfeld R; Vincent A
    Neurology; 2007 Mar; 68(13):1076-7. PubMed ID: 17287449
    [No Abstract]   [Full Text] [Related]  

  • 47. Reply to "'Thinking without thinking' about natalizumab and PML".
    Houff S; Berger JR
    J Neurol Sci; 2008 Jan; 264(1-2):198-9; author reply 199. PubMed ID: 17936798
    [No Abstract]   [Full Text] [Related]  

  • 48. [Multiple sclerosis: advances in its pathogenesis].
    Godoy J; Court J
    Rev Med Chil; 1982 Jun; 110(6):581-4. PubMed ID: 6761822
    [No Abstract]   [Full Text] [Related]  

  • 49. Isoprinosine in multiple sclerosis treatment: a preliminary study.
    Mazzarello P; Rocchelli B; Poloni M; Delodovici M; Pinelli P
    Schweiz Arch Neurol Neurochir Psychiatr; 1982; 131(2):175-9. PubMed ID: 6187064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Letter: Multiple sclerosis: a fever blister on the brain?
    Ellison GW
    Lancet; 1974 Sep; 2(7881):664. PubMed ID: 4137790
    [No Abstract]   [Full Text] [Related]  

  • 51. Abstracts of workshop on cellular and humoral components of CSF in multiple sclerosis. NATO advanced research workshop. Hengelhoef, Limburg, Belgium, April 20-24, 1986.
    Acta Neurol Belg; 1986; 86(3):170-212. PubMed ID: 3739619
    [No Abstract]   [Full Text] [Related]  

  • 52. The association between anti-EBNA-1 IgG and multiple sclerosis clinical disease activity.
    Bahreini SA; Zahednasab H; Saadatnia M; Jabalameli MR
    Eur J Neurol; 2010 Oct; 17(10):e95; author reply e96. PubMed ID: 20636367
    [No Abstract]   [Full Text] [Related]  

  • 53. Search for a multiple sclerosis-specific brain antigen.
    Chou CH; Chou FC; Tourtellotte WW; Kibler RF
    Neurology; 1983 Oct; 33(10):1300-4. PubMed ID: 6193455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunoglobulins in multiple sclerosis].
    Cendrowski W
    Postepy Hig Med Dosw; 1973; 27(4):499-505. PubMed ID: 4732719
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on humoral immunity and HLA antigens in multiple sclerosis, optic neuritis and hereditary optic atrophy.
    Stendahl-Brodin L
    Acta Ophthalmol Suppl; 1982; 149():5-112. PubMed ID: 6282034
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of prostaglandins in altered leukocyte function in multiple sclerosis.
    Dore-Duffy P; Ho SY; Longo M
    Springer Semin Immunopathol; 1985; 8(3):305-19. PubMed ID: 3901371
    [No Abstract]   [Full Text] [Related]  

  • 57. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
    Tourbah A; Fontaine B; Lyon-Caen O
    Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skin-fixing antibodies and neurological disorders.
    Ansari KA
    Trans Am Neurol Assoc; 1970; 95():198-200. PubMed ID: 5514367
    [No Abstract]   [Full Text] [Related]  

  • 59. [New understanding of the immunopathogenesis of multiple sclerosis].
    Rosche B; Kieseier B; Hartung HP; Hemmer B
    Nervenarzt; 2003 Aug; 74(8):654-63. PubMed ID: 12904867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antibody reaction to basic myelin proteins after intracisternal administration into animals].
    Mendzheritskiĭ AM
    Vopr Med Khim; 1984; 30(5):106-10. PubMed ID: 6084891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.